When a critically injured patient is admitted to the hospital, how much supplemental oxygen should they receive? Research ...

Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...

This week’s Healthcare Hero is Shileen Murray, a Cardiac Rehabilitation and Secondary Prevention Nurse specialist, hailing from ...

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

A recent study finds most critically injured patients can recover with less supplemental oxygen than has previously been suggested.

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs ...